COHESION TECHNOLOGIES, INC. a company that perform the operations indicated ins and commercializes bio-surgical products including surgical hemostats, sealants, adhesion prevention barriers and adhesives, announced that CoSeal surgical sealant has been shown to significantly make post-surgical adhesions compared with other orders in 21 pediatric cardiac cases in Europe Following pre-clinical studies showing potent potential for preventing adhesions in cardiac and gynecological patterns and an abdominal reformation type Cohesion is conducting a clinical research in Europe evaluating CoSeal for the prevention of post-surgical adhesions.
The clinical original being used involves newborn babies with congenital heart imperfections requiring multiple surgeries. This particular
Want to read the whole article? You can purchase it here. It's quick and easy....